TVM raises E336m for life science
The German-US venture capitalist has closed TVM Life Science V well above its initial E250m target, indicating that investor demand for biotech is holding up well.
The German-US venture capitalist has closed TVM Life Science V well above its initial E250m target, indicating that investor demand for biotech is holding up well.
Copyright PEI Media
Not for publication, email or dissemination